RGEN
Repligen Corporation
147.13
1 x 147.12
4 x 147.20
bid
ask
+
2.25
1.55%
1 @ 06:57 PM
148.95 +1.82 (1.24%)
Ytd-10.21%
1y21.26%
142.89
day range
147.25
100.99
52 week range
175.77
Open143.88Prev Close144.88Low142.89High147.25Mkt Cap8.14B
Vol514.66KAvg Vol1.15MEPS0.91P/E158.50Forward P/E56.62
Beta1.06Short Ratio5.46Inst. Own120.82%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg125.54200-d Avg139.521yr Est177.05
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-052026-030.380.480.126.32%
2026-02-242025-120.440.490.0511.36%
2025-10-282025-090.420.460.049.52%
2025-07-292025-060.40.37-0.03-7.50%
2025-04-292025-030.350.390.0411.43%
2025-02-202024-120.410.440.037.32%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-07BenchmarkUpgradeHoldBuy
2026-07-06Evercore ISI GroupUpgradeOutperformOutperform
2026-06-03HSBCUpgradeBuyBuy
2026-05-06JP MorganUpgradeOverweightOverweight
2026-05-06BarclaysUpgradeOverweightOverweight
2026-04-20Canaccord GenuityUpgradeHoldHold
Profile
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2026-03-04BYLUND JAMESChief Operating Officer25.42KStock Award(Grant)
2026-05-13DAWES KAREN ADirector92.82KStock Award(Grant)
2025-12-30DOUGLASS BRIAN ROBBOfficer8.54KStock Award(Grant)
2026-05-13EGLINTON MANNER CARRIEDirector5.46KStock Award(Grant)
2026-06-24GARLAND JASON K.Chief Financial Officer19.36KSale
2025-11-12HUNT ANTHONY JOHNDirector83.70KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30BlackRock Inc5.99M0.0010.62%
2025-12-30Vanguard Group Inc4.99M0.008.85%
2026-03-30T. Rowe Price Associates, Inc.4.88M0.008.65%
2026-03-30FMR Inc2.89M0.005.12%
2026-03-30United Capital Financial Advisers Inc2.77M0.004.92%
2026-03-30Vanguard Capital Management, LLC2.40M0.004.25%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-05-28iShares Core S&P Mid-Cap ETF1.80M0.003.18%
2026-04-29Vanguard Total Stock Mkt Idx Inv1.71M0.003.04%
2026-03-30US Small-Cap Growth II Equity Comp1.26M0.002.23%
2026-04-29Vanguard Small Cap Index1.23M0.002.19%
2026-04-29T. Rowe Price New Horizons1.23M0.002.18%
2026-04-29MFS Mid Cap Growth A862.37K0.001.53%